The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Month: February 2024

Women’s Health: The Next Microbiome Frontier
Editor's Choice

Women’s Health: The Next Microbiome Frontier

FEB 20, 2024
Navigating microbiome innovations: Strategic partnerships in Live Biotherapeutic product development
Finance

Navigating microbiome innovations: Strategic partnerships in Live Biotherapeutic product development

FEB 14, 2024
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
Biotics and Supplements

Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation

FEB 8, 2024
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
Finance

Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update

FEB 8, 2024
New technology unscrambles the chatter of microbes
Editor's Choice

New technology unscrambles the chatter of microbes

FEB 7, 2024
Researchers discover link between stress and the gut virome
Editor's Choice

Researchers discover link between stress and the gut virome

FEB 5, 2024